RichardCReichmanMD

Grant Support

• Units For HIV/AIDS Clinical Trials NetworksNational Institute Of Allergy And Infectious Diseases2007
• Training Program In Viral Diseases,Vaccines/ BiodefenseNational Institute Of Allergy And Infectious Diseases2003–2007
• Adult AIDS Clinical Trials Unit (AACTU)National Institute Of Allergy And Infectious Diseases2000–2006
• Twice &Once Daily Antiretroviral Therapy, Self Admin VS Direct ObservationNational Center For Research Resources2005
• Study To Evaluate Antiretroviral Effect Of MRK AD5 HIV Vaccine In HIV-1 + IndivNational Center For Research Resources2005
• Safety And Efficacy Of SCH 417690 (An Orally Administered HIV-1 Entry Inhibitor)National Center For Research Resources2005
• Long-Term Antiviral Management Of Hepatitis C Virus &Hiv-1 Coinfected SubjectsNational Center For Research Resources2005
• Antiretroviral Therapy For Hiv-Infected Adults W/ Opportunisitic InfectionsNational Center For Research Resources2005
• ACTG A5142: Comparison Study Of Three Antiretroviral Treatment Regimens In HIVNational Center For Research Resources2005
• ACTG A5116: Two Potent Simplified Regimens Using Pi-Sparing RegimenNational Center For Research Resources2005
• ACTG A5095: Phase III, Comparison Of Three Protease Inhibitor-Sparing RegimensNational Center For Research Resources2005
• ACTG A5090: Study Of Selegiline Transdermal System In HIV Cognitive ImpairmentNational Center For Research Resources2005
• ACTG A5077: Virologic Studies In Compartmental Samples From Hiv-Infected SubjectNational Center For Research Resources2005
• ACTG A5068: Intermittent Withdrawal Of ART As An Immunization StrategyNational Center For Research Resources2005
• ACTG A5030: Trial Of Valganciclovir Pre-Emptive Therapy For CMV ViremiaNational Center For Research Resources2005
• ACTG A5001: Longitudinal Linked Randomized Trials (ALLRT) ProtocolNational Center For Research Resources2005
• ACTG 736: Cerebrospinal Fluid HIV-1 And Cognitive Function In IndividualsNational Center For Research Resources2005
• A5186 Trial Of Combination Therapy On Triglyceride Levels In Subjects On Haart TNational Center For Research Resources2005
• A5170: Predictors Of Immunologic &Clinical Progression In Subjects WHO Stop ARTNational Center For Research Resources2005
• A5163: Phase II Study Of Once-Weekly Alendronate In Hiv-Infected SubjectsNational Center For Research Resources2005
• ACTG 362: Trial To Determine Time To Development Of AIDS Complications &InfectNational Center For Research Resources2004–2005
• ACTG A5142: Comparison Study Of Three Antiretroviral TxNational Center For Research Resources2004
• ACTG A5117: Development Of Symmetrical PolyneuropathyNational Center For Research Resources2004
• ACTG A5116: Two Potent Simplified RegimensNational Center For Research Resources2004
• ACTG A5093: PK Interaction B/W Depo-Provera &ProteaseNational Center For Research Resources2004
• ACTG A5090: Study Of Selegiline Transdermal SystemNational Center For Research Resources2004
• ACTG A5001: Longitudinal Linked Randomized Trial (ALLRT)National Center For Research Resources2004
• ACTG 736: Cerebrospinal Fluid HIV-1 And CognitionNational Center For Research Resources2004
• A5163: Phase II Study Of Once-Weekly AlendronateNational Center For Research Resources2004
• Booster Dose Of Medi 501 In Volunteers From Mi-Cp028National Center For Research Resources2000–2002
• ACTG 5051--Interleukin 2 Combination W/ AntiretroviralNational Center For Research Resources2000–2002
• ACTG 392--High Protein Supplement In HIV+ SubjectsNational Center For Research Resources2000–2002
• ACTG 384--Protease Inhibitor/ Reverse Transcriptase InhiNational Center For Research Resources2000–2002
• ACTG A5025: S&E Of Hydroxyurea In Subjects On Potent Antiretroviral TNational Center For Research Resources1999–2002
• ACTG 398: Trial Of Amprenavir Dual Protease Inhibitor Regime In CombiNational Center For Research Resources1999–2002
• ACTG 388: Phase III Trial Of Efavirenz Or Nelfinavir In Combo W/ 3tc/National Center For Research Resources1999–2002
• ACTG 372:Ph II Prolongation Of Virologic Succ &Fail PTS Receive INDNational Center For Research Resources1999–2002
• ACTG 362: Trial To Determine Efficacy Of Azithromycin For Mycobac AviNational Center For Research Resources1999–2002
• ACTG 368--A Randomized, Double Blind, Phase II Study Of Indinavir SulfateNational Center For Research Resources1998–2002
• ACTG 343--A Prospective Db, Trial Of Three Therapys Of Zdv, 3TC And IDVNational Center For Research Resources1998–2002
• ACTG 328-- Study Of Rhil2 By IV Or Subq Admin In Subjects With HIV InfectionNational Center For Research Resources1998–2002
• ACTG 323/Msg40--Use Of Fluconazole As Chronic Supr Therapy VS Episodic TherapyNational Center For Research Resources1998–2002
• ACTG 301--A Rand, Db, PC Of Memantine For AIDS Dementia ComplexNational Center For Research Resources1998–2002
• Donation Of ONE Unit Of BloodNational Center For Research Resources1996–2002
• Rdb, Phase 3 Indindavir Sulfate, Zdv, 3TC, Subjects With HIV InfectionNational Center For Research Resources1997–2001
• Influence Of Risk Status For Disease ProgressionNational Center For Research Resources1997–2001
• Atcg 290--Randomized Study Of The Virologic And ImmunologicNational Center For Research Resources1996–2001
• PH I Study Of S T &I Of Medi 501, Virus LIKE Particle (VLP) PappilomNational Center For Research Resources1999–2000
• Ol, R, Study Of Delavirdine Mesylate W/ ZDV &Indinavir VS Zdv, 3TC &National Center For Research Resources1999–2000
• Women'S Health AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• Pharmacology AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• Outreach AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• Outcomes Committee AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• Neurology AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• Immunology And Immune Based Therapy AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• HIV Disease Research AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• Core--Advanced Technology LaboratoriesNational Institute Of Allergy And Infectious Diseases1996–1999
• Complications Of HIV Disease AgendaNational Institute Of Allergy And Infectious Diseases1996–1999
• Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1993–1999
• Virologic Responses To New Nucleoside Regimens After Long Zdv/DdiNational Center For Research Resources1997
• Evaluation Of Differences Among Antiretroviral TherapiesNational Center For Research Resources1997
• Trial Comparing ZDV VS ZDV PLUS DDI VS ZDV PLUS DDI PLUS NevirapineNational Center For Research Resources1996–1997
• Phase II Double Blind Study Of Delavirdine Mesylate PLUS ZDV Or AZTNational Center For Research Resources1996–1997
• ACTG 266--Cytomegalovirus RetinitisNational Center For Research Resources1996–1997
• ACTG 260--Phase I/II Trial Of The Antihiv Activity Of Delavirdine MesylateNational Center For Research Resources1996
• ACTG 152--Comparative Trial Of ZDV VS DDI VS ZDV PLUS DDI In ChildrenNational Center For Research Resources1996
• Institutional Training Awards For AIDS Clinical ResearchNational Institute Of Allergy And Infectious Diseases1994–1996
• Combination Therapy For Patients With Condyloma AcuminaNational Institute Of Allergy And Infectious Diseases1988–1996
• AIDS Clinical TrialsNational Institute Of Allergy And Infectious Diseases1994–1995
• Core--Virology Core LaboratoryNational Institute Of Allergy And Infectious Diseases1992–1995
• Adult Clinical CoreNational Institute Of Allergy And Infectious Diseases1992–1995
• Treatment Of Condyloma Acuminatun With B-Interferon PLUS CryotherapyNational Center For Research Resources1993
• Outcome Of Patients With Condyloma Acuminatum Treated With CryotherapyNational Center For Research Resources1993
• Donation Of Unit Of Blood For Research-Normal VolunteersNational Center For Research Resources1993
• Compare ZDV VS DDI VS ZDV PLUS DDI In Symptomatic HIV Infected ChildrenNational Center For Research Resources1993
• Bioavailability Of Zidovudine Under Fasting And Non-Fasting ConditionsNational Center For Research Resources1993
• Efficacy Of 2'3'-Ddi Orally Twice/Day To Zidovudine Intolerant AIDS PatientsNational Center For Research Resources1992
• Establishment Of An AIDS Clinical Trials GroupNational Institute Of Allergy And Infectious Diseases1989–1992
• 2',3'Didexyinosine Administered In Patients With AIDS Or ARCNational Center For Research Resources1990
• Production Of HPV6 Antigens &Studies Of Genital DiseaseNational Institute Of Allergy And Infectious Diseases1989
• Wellferon On Condyloma AcuminataNational Center For Research Resources1985